Understanding molecular mechanisms involved in vascular aging is essential to develop novel interventional strategies for treatment and prevention of age-related vascular pathologies. Recent studies provide critical evidence that vascular aging is characterized by NAD+ depletion. Importantly, in aged mice, restoration of GeroScience (aging effects of NAD+ booster treatments and determine the links between miRNAs regulated by NMN and sirtuin activators and miRNAs known to act in the conserved pathways of aging and major aging-related vascular diseases.
cellular NAD+ levels by treatment with the NAD+ booster nicotinamide mononucleotide (NMN) exerts significant vasoprotective effects, improving endothelium-dependent vasodilation, attenuating oxidative stress, and rescuing age-related changes in gene expression. Strong experimental evidence shows that dysregulation of microRNAs (miRNAs) has a role in vascular aging. The present study was designed to test the hypothesis that age-related NAD+ depletion is causally linked to dysregulation of vascular miRNA expression. A corollary hypothesis is that functional vascular rejuvenation in NMN-treated aged mice is also associated with restoration of a youthful vascular miRNA expression profile. To test these hypotheses, aged (24-month-old) mice were treated with NMN for 2 weeks and miRNA signatures in the aortas were compared to those in aortas obtained from untreated young and aged control mice. We found that protective effects of NMN treatment on vascular function are associated with antiaging changes in the miRNA expression profile in the aged mouse aorta. The predicted regulatory effects of NMNinduced differentially expressed miRNAs in aged vessels include anti-atherogenic effects and epigenetic rejuvenation. Future studies will uncover the mechanistic role of miRNA gene expression regulatory networks in the anti-
Introduction
Age-related diseases of the cardiovascular system are a leading cause of morbidity and mortality in the elderly (Abdellatif et al. 2018; Minamino and Komuro 2007; Wang and Bennett 2012; Alfaras et al. 2016; Ungvari et al. 2018) . Vascular aging is associated with stiffening of the large arteries, endothelial dysfunction, oxidative stress, and inflammation, promoting the development of atherosclerotic vascular diseases (ischemic heart diseases, stroke, peripheral artery disease) and aorta aneurysm (Wang and Bennett 2012; Ungvari et al. 2018) . Microvascular aging is also a major contributing factor to the pathogenesis of vascular cognitive impairment (VCI), Alzheimer's disease, cerebral microhemorrhages, sarcopenia, heart failure, chronic kidney disease and Mullins et al. 2014; Ungvari et al. 2017a; Toth et al. 2017; Tarantini et al. 2017a; Tarantini et al. 2016a; Sagare et al. 2013; Sweeney et al. 2018; Montagne et al. 2017; Kisler et al. 2017; Payne 2006; Hoenig et al. 2008; Long et al. 2012) . Understanding molecular mechanisms involved in vascular aging is essential to develop novel interventional strategies for treatment and prevention of age-related vascular pathologies.
MicroRNAs (miRNA) are short, endogenous, noncoding transcripts that repress gene expression at the post-transcriptional level in both physiological and pathological conditions. Strong experimental evidence suggest that miRNAs have a role in regulation of lifespan in model organisms (Boehm and Slack 2005; Grillari and Grillari-Voglauer n.d.; Ibanez-Ventoso et al. 2006 ) and that alterations in cellular miRNA expression profile also play a role in mammalian aging (Bates et al. n.d.; Maes et al. 2008; Inukai et al. 2012; Inukai and Slack 2013; Ito et al. 2010; Mercken et al. 2013; Smith-Vikos and Slack 2012; Ungvari et al. 2013a; Zhang et al. 2012; Zovoilis et al. 2011; Smith-Vikos et al. 2016; ElSharawy et al. 2012) . Importantly, miRNAs were also reported to regulate several important aspects of endothelial biology and vascular function (Bonauer et al. 2009; Doebele et al. n.d.; Kuehbacher et al. 2007; Chen et al. 2015a; Hergenreider et al. 2012; Kim et al. 2014; Leung et al. 2013; Lovren et al. 2012; O'Rourke and Olson 2011; Rotllan et al. 2013; Stellos and Dimmeler 2014; Weber et al. 2014; Zampetaki et al. 2014) . Several studies have demonstrated that agerelated miRNA dysregulation importantly contributes to the development of vascular aging phenotypes (Ito et al. 2010; Ungvari et al. 2013a,b; Menghini et al. 2014; Badi et al. 2018; Guo et al. 2017; Hazra et al. 2016; Regina et al. 2016; Boon et al. 2013; ) and promotes the pathogenesis of atherosclerotic diseases (Ono et al. 2011 ) encompassing every step from sterile vascular inflammation, plaque formation to plaque destabilization and rupture (Hartmann et al. 2016; Lu et al. 2018; Zhang et al. 2018) . Dysregulation of miRNA expression has also been linked to microvascular aging phenotypes, including impaired angiogenesis (Ungvari et al. 2013b; Che et al. 2014; Jansen et al. 2015) . Experimental interventions that both extend lifespan and prevent/delay age-related vascular dysfunction in rodents, including caloric restriction ) and induction of earlylife IGF-1 deficiency (Tarantini et al. 2016b) , were shown to reverse aging-induced alterations in vascular miRNA expression. Despite these advances, fundamental cellular and molecular processes of aging that are responsible for dysregulation of vascular miRNA expression have not been elucidated.
NAD + is a rate-limiting co-substrate for sirtuin enzymes, which are key regulators of pro-survival pathways in the vasculature (Das et al. 2018; Csiszar et al. 2009a; Csiszar et al. 2009b; . Aging is associated with cellular NAD + depletion (Gomes et al. 2013; Massudi et al. 2012) , which has been proposed to be a critical driving force of aging processes. In support of this theory, it was demonstrated that enhancing NAD + biosynthesis extends lifespan in lower organisms (Anderson et al. 2002) and improves health-span in mouse models of aging (Mitchell et al. 2018) . Recent studies provide critical evidence that vascular aging is also characterized by NAD+ depletion Kiss et al. 2019) . Importantly, we 69 and other laboratories demonstrated (Das et al. 2018; de Picciotto et al. 2016 ) that in aged mice restoration of cellular NAD + levels by treatment with the NAD+ precursor nicotinamide mononucleotide (NMN) (Yoshino et al. 2018) confers potent anti-aging vascular effects, reversing endothelial dysfunction, improving mitochondrial function, and attenuating oxidative stress.
The present study was designed to test the hypothesis that age-related NAD+ depletion is causally linked to dysregulation of vascular miRNA expression. A corollary hypothesis is that functional vascular rejuvenation in NMN-treated aged mice is also associated with restoration of a youthful vascular miRNA expression profile. To test these hypotheses, aged mice were treated with NMN for 2 weeks and miRNA signatures in the aortas were compared to those in aortas obtained from untreated young and aged control mice.
Methods

Animals, NMN supplementation
Young (3-month-old) and aged (24-month-old) male C57BL/6 mice were purchased from the aging colony maintained by the National Institute on Aging at Charles River Laboratories (Wilmington, MA). The biological age of 24-month-old mice corresponds to that of~60-year-old humans. Mice were housed under specific pathogen-free barrier conditions in the Rodent Barrier Facility at University of Oklahoma Health Sciences Center under a controlled photoperiod (12 h light; 12 h dark) with unlimited access to water and were fed a standard AIN-93G diet (ad libitum). Mice in the aged cohort were assigned to two groups. One group of the aged mice was injected daily with NMN (i.p. injections of 500 mg NMN/kg body weight per day) or the equivalent volume of PBS for 14 consecutive days at 6 PM and 8 AM on day 14 and were sacrificed 4 h after last injection. Similar dosages of NMN have been shown to exert potent anti-aging effects on mouse health span (de Picciotto et al. 2016) . All procedures were approved by the Institutional Animal Use and Care Committees of the University of Oklahoma Health Sciences Center. All animal experiments complied with the AR-RIVE guidelines and were carried out in accordance with the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) . The effects of NMN treatment on cognitive function, cerebromicrovascular responses, and aorta endothelial function in the same cohort of mice have been recently reported .
Quantitative real-time RT-PCR and miRNA expression profiling
A quantitative real time RT-PCR technique was used to analyze miRNA expression profiles in the aorta of mice from each experimental group as reported (Ungvari et al. 2013b; Tarantini et al. 2016b ). In brief, total RNA was isolated with a mirVana™ miRNA Isolation Kit (ThermoFisher Scientific) and was reverse transcribed using TaqMan® MicroRNA Reverse Transcription Kit as described previously (Ungvari et al. 2013b; Tarantini et al. 2016b ). The expression profile of mouse miRNAs in aortas derived from young and aged control mice and aged NMNtreated mice was analyzed using the TaqMan Array Rodent MicroRNA A+B Cards Set v3.0 (ThermoFisher Scientific). The qPCR data were quantified using the ΔΔCt method (Livak and Schmittgen 2001) . Predicted and experimentally validated microRNA targets were obtained from the TargetScan database (Agarwal et al. 2015) , and Gene Ontology enrichment analysis was performed on differentially expressed microRNA targets using Fisher's exact test between TargetScan targets and annotations from the Gene Ontology database (Harris et al. 2004) . To identify relationships between miRNA targets and terms in the biomedical literature, we utilized the IRIDESCENT system (Wren and Garner 2004) . IR-IDESCENT uses a statistical model to determine whether each target gene co-occurs with a term of interest more frequently than would be expected by chance, and quantifies this in terms of the mutual information measure.
Results
Changes in vascular miRNA expression profile in mice associated with aging and with NMN treatment
We assessed changes in miRNA expression in the mouse aorta associated with aging and with NMN treatment. Hierarchical clustering ( Fig. 1a ) and principal component analysis ( Fig. 1b ) of miRNA expression showed a clear separation between the young and aged groups. Aged control mice and aged NMN-treated mice were also separated in the principal component analysis and hierarchical clustering. In contrast, miRNA expression in young mice and NMN-treated aged mice was similar and these groups did not separate well in the principal component analysis and hierarchical clustering. The Venn diagram in Fig. 1c shows that expression of several miRNAs, which are differentially expressed in the aortas of young and aged mice, was restored to youthful levels in aortas of NMN-treated aged mice. These data suggest that NAD + depletion has a critical role in age-related dysregulation of vascular miRNA expression. Figure 2 shows changes in expressions of individual miRNAs in the mouse aorta associated with age and NMN treatment.
Since the discovery of miRNA regulation of genes, several studies have been focused on predicting the biologically relevant target genes for miRNAs. We have used TargetScan database to predict putative biological targets of miRNAs differentially expressed with age whose expression is restored to youthful levels in aortas of aged mice by NMN supplementation (Table 1) . GO terms enriched among miRNAs differentially expressed with age whose expression is restored to youthful levels in aortas of aged mice by NMN supplementation are shown in Table 2 . Analysis of the differentially expressed miRNAs indicated that a statistically significant number of them had target sites within genes associated with pathways regulating the intracellular signaling, protein homeostasis, and inflammation ( Table 2 ). The results are consistent with the predicted anti-aging effects of NMN treatment. The heat map is a graphic representation of normalized miRNA expression values in aortas derived from young (3-month-old), aged (24-month-old), and NMNtreated aged mice. Hierarchical clustering analysis revealed the similarities on miRNA expression profiles of aortas from young and NMNtreated aged mice. b Principal component analysis (PCA) plot of miRNA expression profiles from aortas derived from young, aged control, and NMN-treated aged mice. The profiles from aged mice (red dots) cluster separately to clusters representative of young mice (blue circles) and NMN-treated aged mice (green triangles). PC1 and PC2: Principal components 1 and 2, respectively. c Venn diagrams showing the differentially expressed miRNAs in each group, which are significantly up-or down-regulated in aortas from aged mice compared to those from young mice or aged NMN-treated mice
We also attempted to predict the biological effects of the differentially expressed miRNAs by identifying relationships between miRNA targets and terms in the biomedical literature utilizing the IRIDESCENT system (Wren and Garner 2004) . The results of this analysis suggest that NMN supplementation likely promotes epigenetic rejuvenation and confers anti-atherogenic effects (Table 3) .
Discussion
Our study demonstrates that protective effects of NMN treatment on vascular function is associated with antiaging changes in the miRNA expression profile in the aorta in a mouse model of aging that recapitulates vascular alterations and deficits present in elderly humans at risk for cardiovascular and cerebrovascular diseases.
Age-related changes in vascular miRNA expression likely play important pathogenic roles targeting critical signaling pathways, inflammatory processes, and cellular mechanisms involved in protein homeostasis and thereby impairing the structural and functional integrity of the vasculature (Fig. 3 ). Among others, miR-29a , miR-27b (Signorelli et al. 2016) , miR-652 (Pilbrow et al. 2014) , miR-221 (Wei et al. 2013) , miR-28 , miR-21 (Urbich et al. 2008) , miR-125b-5p (Ohukainen et al. 2015) , miR-494 (Wezel et al. 2015) , and miR-145 (Faccini et al. 2017) , which are up-regulated in aging, have been implicated in vascular inflammation and atherogenesis. (Sakamoto et al. 2011) To our knowledge, this is the first study to demonstrate that NMN treatment in aged mice reverses, at least in part, age-related, pro-inflammatory, and pro-atherogenic alterations in miRNA expression profile in the aorta. These findings raise the possibility that changes in post-transcriptional control of expression of genes that encode critical targets for vascular health contribute to the beneficial effects of treatment with NAD+ boosters on health span. Demonstration of NMN-induced changes in miRNA biology in the vasculature is particularly important as alterations in miRNA expression profile have been causally linked to the development of cardiovascular aging phenotypes (Ungvari et al. 2013a; Boon et al. 2013; ) and the pathogenesis of cardiovascular diseases (Ono et al. 2011) . A single miRNA can target up to several hundred mRNAs, thus capable of significantly altering gene expression regulatory networks. Systematic prediction of target pathways supports the concept that chronic NMN treatment may exert significant anti-atherogenic effects via epigenetic rejuvenation of the vasculature. These miRNA-mediated vasoprotective effects of NMN treatment appear to be synergistic with its endothelial protective, anti-aging, and pro-angiogenic effects demonstrated by recent studies Kiss et al. 2019) .
The molecular mechanisms contributing to aging-induced decline in NAD + in the vasculature are likely multifaceted and may include downr e g u l a t i o n o f n i c o t i n a m i d e phosphoribosyltransferase (NAMPT, also known as NMN synthase; which catalyzes the rate limiting step in the biosynthesis of NAD + ) ) and increased utilization of NAD + by activated Poly [ADP-ribose] polymerase 1 (PARP-1) Pacher et al. 2002) . Additional studies are warranted to determine the efficacy of combination treatments that simultaneously increase NAD+ production and inhibit its degradation (e.g., NMN plus a PARP-1 inhibitor) for the prevention of age-related vascular pathologies.
Previous studies demonstrate that restoration of NAD + levels by NMN treatment exert protective effects on endothelial vasodilation in aged rodents by reducing ROS generation and restoring mitochondrial function in a sirtuin-dependent manner . The mechanisms by which NAD+ boosters regulate miRNA expression are likely multifaceted and may include both transcriptional and post-transcriptional regulatory mechanisms ( Fig. 3) . NMN-induced transcriptional regulation may involve changes in the expression of miRNA genes due to altered transcription factor activity, changes in genome accessibility (e.g., histone modifications), and altered methylation status of the promoter of the miRNA genes. Post-transcriptional mechanisms affected by NMN treatment may include rescue of miRNA processing pathways (Ungvari et al. 2013b ) and miRNA stability. Activation of sirtuins by NAD+ boosters, which has been linked to attenuation of age-related vascular oxidative stress Kiss et al. 2019) , may potentially contribute to both transcriptional and post-transcriptional regulation of miRNA expression in the vasculature. In particular, future Table 3 Literature commonalities of the genes targeted by miRNAs whose expression is restored to youthful levels in aortas of aged mice by NMN supplementation. The IRIDESCENT literature-mining software was used to identify commonalities (e.g., genes, diseases, phenotypes, biological processes) of the genes predicted to be targeted by the miRNAs. (Ungvari et al. 2013b ). Further, the anti-aging vascular effects of caloric restriction also have been causally linked to sirtuin activation (Csiszar et al. 2009a) . Importantly, caloric restriction also promotes significant anti-inflammatory and anti-atherogenic changes in vascular miRNA expression . Various humoral factors (e.g., hormones, cytokines) can also affect vascular miRNA expression. Additional studies are needed to determine the indirect effects of NMNinduced changes in humoral factors (e.g., adipokines) on vascular miRNA expression profile. The available evidence also supports the concept that a bi-directional link exists between NAD+ levels and miRNA expression (Choi et al. 2013) .
Recent studies identify the miR-34a/NAMPT (nicotinamide phosphoribosyltransferase) regulatory axis, which regulates SIRT1 activity through altering NAD+ levels (Choi et al. 2013) . Interestingly, miR-34a tends to be increased in the aged mouse aorta (~2.9-fold), which associates with a downregulation of NAMPT .
Conclusions
In conclusion, rescue of vascular function and attenuation of oxidative stress in the vasculature of NMN-treated aged mice is accompanied by antiaging changes in miRNA expression profile in the aorta. The predicted regulatory effects of NMNinduced differentially expressed miRNAs in aged vessels include anti-atherogenic affects and epigenetic rejuvenation (Fig. 3) and are consistent with the anti-aging functional effects of treatment with both NMN (Das et al. 2018; Tarantini et al. 2019; Kiss et al. 2019; de Picciotto et al. 2016 ) and sirtuin activators (Pearson et al. 2008; Csiszar et al. 2012; Mattison et al. 2014; Toth et al. 2015; Toth et al. 2014; Zhang et al. 2009; Oomen et al. 2009; Minor et al. 2011; Chen et al. 2015b; Gano et al. 2014) observed both in vivo and ex vivo. We hope that our findings will facilitate future endeavor of uncovering the mechanistic role of miRNA gene expression regulatory networks in the anti-aging effects of NAD+ booster treatments. Future studies should also investigate the links between miRNAs (Sullivan et al. 2019) regulated by NMN and sirtuin activators and miRNAs known to act in the conserved pathways of aging Menghini et al. 2014; Tarantini et al. 2016b; Kennedy et al. 2014; An et al. 2017; Ashpole et al. 2017; Bennis et al. 2017; Deepa et al. 2017; Fang et al. 2017; Fulop et al. 2018; Lee et al. 2018; Reglodi et al. 2018; Menghini et al. 2009; Fan et al. 2018 ) and major aging-related diseases Meschiari et al. 2017; Tarantini et al. 2017b; Tucsek et al. 2017; Ungvari et al. 2017b; Carlson et al. 2018; Csipo et al. 2018; Tana et al. 2017; Feinberg and Moore 2016) . Potentially, miRNA-regulated anti-aging mechanisms of NAD+ booster treatments and sirtuin activators could be harnessed for development of new pharmacological approaches for the prevention and treatment of age-related vascular diseases.
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